TY - JOUR
T1 - Replicase-based plasmid DNA shows anti-tumor activity
AU - Rodriguez, B. Leticia
AU - Yu, Zhen
AU - Chung, Woon Gye
AU - Weiss, Richard
AU - Cui, Zhengrong
N1 - Funding Information:
This work was supported in part by National Cancer Institute grants CA135274 (to ZC) and CA135274-S1 (to BLR and ZC).
PY - 2011/3/28
Y1 - 2011/3/28
N2 - Background: Double stranded RNA (dsRNA) has multiple anti-tumor mechanisms. Over the past several decades, there have been numerous attempts to utilize synthetic dsRNA to control tumor growth in animal models and clinical trials. Recently, it became clear that intracellular dsRNA is more effective than extracellular dsRNA on promoting apoptosis and orchestrating adaptive immune responses. To overcome the difficulty in delivering a large dose of synthetic dsRNA into tumors, we propose to deliver a RNA replicase-based plasmid DNA, hypothesizing that the dsRNA generated by the replicase-based plasmid in tumor cells will inhibit tumor growth.Methods: The anti-tumor activity of a plasmid (pSIN-β) that encodes the sindbis RNA replicase genes (nsp1-4) was evaluated in mice with model tumors (TC-1 lung cancer cells or B16 melanoma cells) and compared to a traditional pCMV-β plasmid.Results: In cell culture, transfection of tumor cells with pSIN-β generated dsRNA. In mice with model tumors, pSIN-β more effectively delayed tumor growth than pCMV-β, and in some cases, eradicated the tumors.Conclusion: RNA replicase-based plasmid may be exploited to generate intracellular dsRNA to control tumor growth.
AB - Background: Double stranded RNA (dsRNA) has multiple anti-tumor mechanisms. Over the past several decades, there have been numerous attempts to utilize synthetic dsRNA to control tumor growth in animal models and clinical trials. Recently, it became clear that intracellular dsRNA is more effective than extracellular dsRNA on promoting apoptosis and orchestrating adaptive immune responses. To overcome the difficulty in delivering a large dose of synthetic dsRNA into tumors, we propose to deliver a RNA replicase-based plasmid DNA, hypothesizing that the dsRNA generated by the replicase-based plasmid in tumor cells will inhibit tumor growth.Methods: The anti-tumor activity of a plasmid (pSIN-β) that encodes the sindbis RNA replicase genes (nsp1-4) was evaluated in mice with model tumors (TC-1 lung cancer cells or B16 melanoma cells) and compared to a traditional pCMV-β plasmid.Results: In cell culture, transfection of tumor cells with pSIN-β generated dsRNA. In mice with model tumors, pSIN-β more effectively delayed tumor growth than pCMV-β, and in some cases, eradicated the tumors.Conclusion: RNA replicase-based plasmid may be exploited to generate intracellular dsRNA to control tumor growth.
UR - http://www.scopus.com/inward/record.url?scp=79953111875&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79953111875&partnerID=8YFLogxK
U2 - 10.1186/1471-2407-11-110
DO - 10.1186/1471-2407-11-110
M3 - Article
C2 - 21443770
AN - SCOPUS:79953111875
SN - 1471-2407
VL - 11
JO - BMC cancer
JF - BMC cancer
M1 - 110
ER -